This might be because EGFR activation leads to the suppression of the anti-tumour immune response via the induction of regulatory T-cells or reduction in the levels of T-cell chemoattractants, facilitating immune system evasion by tumour cells44. This evidence concerns the gene EGFR and neoplasm.